Market: NMS |
Currency:
Address:
📈 ONC Historical Chart
📊 Statistics
-
Analyst 1 Year Price Target:
$409.91
-
Upside/Downside from Analyst Target:
20.80%
-
Broker Call:
58
-
Dividend Minimum 3 Year Yield:
0.00%
-
EPS Growth Range (1Y):
50-100%
-
Net Income Growth Range (1Y):
50-100%
-
Revenue Growth Range (1Y):
25-50%
-
Upcoming Earnings Date:
-
💰 Dividend History
No dividend history available.
📅 Earnings & EPS History for ONC
| Date | Reported EPS |
|---|
| 2025-11-10 | - |
| 2025-08-06 | 0.84 |
| 2025-05-07 | 0.01 |
| 2025-02-27 | -1.43 |
| 2024-11-12 | -1.15 |
| 2024-08-07 | -1.15 |
| 2024-05-08 | -2.41 |
| 2024-02-26 | -3.48 |
| 2023-11-09 | 2.01 |
| 2023-08-02 | -3.64 |
| 2023-05-04 | -3.34 |
| 2023-02-27 | -4.29 |
| 2022-11-09 | -5.39 |
| 2022-08-04 | -5.56 |
| 2022-05-05 | -4.24 |
| 2022-02-25 | -6.16 |
| 2021-11-04 | -4.46 |
| 2021-08-05 | -5.23 |
| 2021-05-06 | 0.69 |
| 2021-02-25 | -5.2 |
| 2020-11-05 | -4.81 |
| 2020-08-06 | -4.31 |
| 2020-05-11 | -4.7 |
| 2020-03-02 | -6.39 |
| 2019-11-12 | -5.11 |
📰 Related News & Research
-
Sichuan Biokin Pharmaceutical (688506) Hong Kong IPO: Innovative Oncology Pipeline, Global Strategy & Key Risk Factors Explained
February 14, 2026
Baili Pharmaceutical IPO Analysis: Growth, Strategy & Outlook for Investors Company Name: Baili Pharmaceutical Co., Ltd. Date of Prospectus: November 7, 2025 Baili Pharmaceutical IPO:…
-
UpHealth Group Limited Completes Acquisitions of 812 Capital and CIMT, Expands Oncology and Medical Facilities Network
February 13, 2026
UpHealth Group Limited Completes Transformational Acquisitions and Rebranding UpHealth Group Limited Completes Transformational Acquisitions and Rebranding Key Points Completion of Major Healthcare Acquisitions: UpHealth Group…
-
Once Upon a Farm IPO: Brand Strengths, Growth Strategies, and Industry Leadership in Organic Kids’ Nutrition 514113
January 31, 2026
Once Upon a Farm, PBC IPO Analysis: Key Insights for Investors Once Upon a Farm, PBC Date of Prospectus: January 27, 2026 Once Upon a…
-
ASTI Holdings Responds to Shareholder Concerns on ASA Voluntary Offer and Debt Issues
January 28, 2026
ASTI Holdings: Shareholder Concerns on Pre-Conditional Voluntary Offer by Advanced Systems Automation Limited ASTI Holdings Receives Shareholder Feedback on ASA’s Pre-Conditional Voluntary Offer Key Developments…
-
AcroMeta Enters Indonesian Nickel Trading with Strategic Partnership and Option to Acquire South Konawe Concession 1
January 22, 2026
AcroMeta Group Announces Strategic Entry into Indonesian Nickel Trading via Partnership with PT Esa Jaya Labdagati AcroMeta Group Announces Strategic Entry into Indonesian Nickel Trading…
-
Sichuan Biokin Pharmaceutical Hong Kong IPO: Innovative Oncology Pipeline, Growth Strategies & Global Expansion (2025 Prospectus Highlights)
January 17, 2026
Baili Pharmaceutical: Hong Kong IPO Analysis, Offer Details, Financials & Outlook Baili Pharmaceutical Co., Ltd. Date of Prospectus: November 7, 2025 Baili Pharmaceutical’s Hong Kong…
-
Autagco Ltd. FY2025 Audited Financials: Material Uncertainty on Going Concern, No Dividend Declared
January 13, 2026
Autagco Ltd. FY2025 Financial Analysis: Material Uncertainty Over Going Concern Autagco Ltd., a Singapore-listed investment holding company, has released its audited financial statements for the…
-
Sichuan Biokin Pharmaceutical Hong Kong IPO: Innovative Oncology Drugs, Global Expansion & Key Financials (2025)
January 11, 2026
Baili Pharmaceutical IPO Analysis: Key Details, Financials, Risks, and Outlook Baili Pharmaceutical Co., Ltd. Date of Prospectus: November 7, 2025 Baili Pharmaceutical Hong Kong IPO:…
-
Concord New Energy Group Successfully Achieves Secondary Listing on Singapore Exchange (SGX-ST)
January 6, 2026
Concord New Energy Group Limited: Key Highlights of Successful Secondary Listing on SGX Concord New Energy Group Limited Announces Successful Secondary Listing on Singapore Exchange…
-
Concord New Energy Group Lists on SGX Mainboard, Expanding Global Renewable Energy Presence 1
January 6, 2026
Concord New Energy Group Limited Secondary Listing on SGX: What Investors Need to Know Concord New Energy Group Limited Makes Strategic Secondary Listing on SGX…
🔍 View more Reports
